Heart & Lung: The Journal of Acute and Critical Care
Volume 36, Issue 1 , Pages 64-71 , January 2007

Coccidioides immitis fungemia: Clinical features and survival in 33 adult patients

Presented in-part in Critical Care Medicine 2001;29:12 (supplement) A1061 and Critical Care Medicine 1999;27:A122.2

  • Silke Rempe, MD

      Affiliations

    • Pulmonary/Critical Care Carl T. Hayden VA Good Samaritan Medical Center, Phoenix, Arizona
    • ,
  • Mankanwal S. Sachdev, MD

      Affiliations

    • Hepatology Mayo Clinic-Scottsdale, Scottsdale, Arizona
    • ,
  • Rajesh Bhakta, MD

      Affiliations

    • Premier Physicians, Goodyear, Arizona
    • ,
  • Mauricio Pineda-Roman, MD

      Affiliations

    • Hematology/Oncology Medical University of South Carolina, Charleston, South Carolina
    • ,
  • Austin Vaz, MD

      Affiliations

    • Rheumatology Section, University of Arizona College of Medicine, University Medical Center, Tucson, Arizona
    • ,
  • Richard W. Carlson, MD, PhD, FCCM

      Affiliations

    • Department of Medicine, Maricopa Medical Center, Phoenix, Arizona
    • Mayo Medical School and University of Arizona, Arizona
    • Corresponding Author InformationReprint requests: Richard W. Carlson, MD, PhD, FCCM, Chair, Department of Medicine, Maricopa Medical Center, 2601 E. Roosevelt, Rm 6-B-09, Phoenix, AZ 85008.

References 

  1. Sachdev M, Bhakta R, Pineda-Roman M, Shahryar S, Carlson R. Case series of 29 patients with C. immitis fungemia (CIF). Crit Care Med. 2001;29:A106
  2. Pineda-Roman M, Vaz A, Singh V, Kelly P, Carlson R. The ominous implications of Coccidioides immitis fungemia (CIF): review of 21 patients at a single institution. Crit Care Med. 1999;27:122A
  3. Pappagianis D. Epidemiology of coccidioidomycosis. Curr Top Med Mycol. 1988;2:199–238
  4. Ampel NM, Ryan KJ, Carry PJ, Wieden MA, Schifman RB. Fungemia due to Coccidioides immitis (An analysis of 16 episodes in 15 patients and a review of the literature). Medicine. 1986;65:312–321
  5. Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection (A review of 77 patients). Medicine. 1990;69:384–391
  6. Gonzalez CE, Venzon D, Lee S, Mueller BU, Pizzo PA, Walsh TJ. Risk factors for fungemia in children infected with human immunodeficiency virus: a case-control study. Clin Infect Dis. 1996;23:515–521
  7. Yozwiak ML, Lundergan LL, Kerrick SS, Galgiani JN. Symptoms and routine laboratory abnormalities associated with coccidioidomycosis. West J Med. 1988;149:419–421
  8. Gilbert R, Keighley JF. The arterial-alveolar oxygen tension ratio (An index of gas exchange applicable to varying inspired oxygen concentrations). Am Rev Respir Dis. 1974;109:142–145
  9. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348:727–734
  10. Wolf JE, Little JR, Pappagianis D, Kobayashi GS. Disseminated coccidioidomycosis in a patient with the acquired immune deficiency syndrome. Diagn Microbiol Infect Dis. 1986;5:331–336
  11. Singh VR, Smith DK, Lawerence J, et al. Coccidioidomycosis in patients infected with human immuno-deficiency virus: review of 91 cases at a single institution. Clin Infect Dis. 1996;23:563–568
  12. Ahmed AJ, Kruse JA, Haupt MT, Chandrasekar PH, Carlson RW. Hemodynamic responses to gram-positive versus gram-negative sepsis in critically ill patients with and without circulatory shock. Crit Care Med. 1991;19:1520–1525
  13. Javaloyas M, Garcia-Somoza D, Gudiol F. Epidemiology and prognosis of bacteremia: a 10-y study in a community hospital. Scand J Infect Dis. 2002;34:436–441
  14. Omenaca C, Turett G, Yarrish R, et al. Bacteremia in HIV-infected patients: short-term predictors of mortality. J Acquir Immune Defic Syndr. 1999;22:155–160
  15. Garbino J, Kolarova L, Rohner P, Lew D, Pichna P, Pittet D. Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital. Medicine. 2002;81:425–433
  16. Lark RL, Saint S, Chenoweth C, Zemencuk JK, Lipsky BA, Plorde JJ. Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis. 2001;41:15–22
  17. Arizona Department of Health Services, Department of Public Health, Bureau of Epidemiology and Disease Control, Office of HIV/STD Services. Arizona HIV/STD Semiannual Surveillance Report. 9 vol. 2002;Arizona
  18. Corry DB, Ampel NM, Christian L, Locksley RM, Galgiani JN. Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. J Infect Dis. 1996;174:440–443
  19. Hofbauer LC, Heufelder AE. Endocrine implications of human immunodeficiency virus infection. Medicine. 1996;75:262–278
  20. Ampel NM, Wieden MA, Galgiani JN. Coccidioidomycosis: clinical update. Rev Infect Dis. 1989;11:897–911
  21. Stevens DA. Coccidioidomycosis. N Engl J Med. 1995;332:1077–1082
  22. Kovacs A, Forthal DN, Kovacs JA, Overturf GD. Disseminated coccidioidomycosis in a patient with acquired immune deficiency syndrome. West J Med. 1984;140:447–449
  23. Antoniskis D, Larsen RA, Akil B, Rarick MU, Leedom JM. Seronegative disseminated coccidioidomycosis inpatients with HIV infection. AIDS. 1990;4:691–693
  24. Arsura EL, Bellinghausen PL, Kilgore WB, Abraham JJ, Johnson RH. Septic shock in coccidioidomycosis. Crit Care Med. 1998;26:62–65
  25. Beaman LV, Pappagianis D, Benjamini E. Mechanisms of resistance to infection with Coccidioides immitis in mice. Infect Immun. 1979;23:681–685
  26. Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med. 1982;142:489–494
  27. Deresinski SC, Stevens DA. Coccidioidomycosis in compromised hosts (Experience at Stanford University Hospital). Medicine. 1975;54:377–395
  28. Drutz DJ, Catanzaro A. Coccidioidomycosis (Part II). Am Rev Respir Dis. 1978;117:727–771
  29. Drutz DJ, Catanzaro A. Coccidioidomycosis (Part I). Am Rev Respir Dis. 1978;117:559–585
  30. Drutz DJ, Huppert M. Coccidioidomycosis: factors affecting the host-parasite interaction. J Infect Dis. 1983;147:372–390
  31. Lopez AM, Williams PL, Ampel NM. Acute pulmonary coccidioidomycosis mimicking bacterial pneumonia and septic shock: a report of two cases. Am J Med. 1993;95:236–239
  32. McNeil MM, Ampel NM. Opportunistic coccidioidomycosis in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis. 1995;21:S111–S113
  33. Polis MA, Kovacs JA. Fungal infections in patients with the acquired immunodeficiency syndrome. In:  DeVita VT,  Hellman S,  Rosemberg SA editor. AIDS: biology, treatment, and prevention. Philadelphia, PA: Lippincott-Raven Publishers; 1997;p. 231–244
  34. Stevens DA. C. immitis. In:  Mandell GL,  Bennett JE,  Dolin R editor. Principles and practice of infectious diseases. New York: Churchill Livingstone; 1995;p. 2365–2375
  35. Galgiani JN, Ampel NM, Catanzaro A, et al. Practice guidelines for the treatment of coccidiomycosis. Clin Infect Dis. 2000;30:658–661

 All authors were at the Maricopa Medical Center at the time of their contribution to this article.Drs. Sachdev and Rempe contributed equally to the article.The authors state that this material has not received commercial support and is not under submission at another publication. We do not have any personal financial interests in the material.

PII: S0147-9563(06)00233-0

doi: 10.1016/j.hrtlng.2006.10.001

Heart & Lung: The Journal of Acute and Critical Care
Volume 36, Issue 1 , Pages 64-71 , January 2007

Article Tools